BISPECIFIC MONOCLONAL ANTIBODIES TO IL-12 AND IL-18

Details for Australian Patent Application No. 2001277022 (hide)

Owner SCHERING AKTIENGESELLSCHAFT

Inventors LEUNG, Stewart; PEREZ, H., Daniel; MIYAMOTO, Neil

Pub. Number AU-A-2001277022

PCT Pub. Number WO2003/008452

Priority 60/219,448 20.07.00 US; 09/907,960 19.07.01 US

Filing date 20 July 2001

Wipo publication date 3 March 2003

International Classifications

C07K 016/28 Immunoglobulins, e.g. monoclonal or polyclonal antibodies

A61K 039/395 Medicinal preparations containing antigens or antibodies - Antibodies

C07K 019/00 Hybrid peptides

C12N 015/13 Mutation or genetic engineering - Immunoglobulins

C12N 005/10 Undifferentiated human, animal or plant cells, e.g. cell lines - Cells modified by introduction of foreign genetic material, e.g. virus-transformed cells

A61P 037/00 Drugs for immunological or allergic disorders

G01N 033/577 Investigating or analysing materials by specific methods not covered by groups - involving monoclonal antibodies

Event Publications

22 May 2003 Application Open to Public Inspection

  Published as AU-A-2001277022

15 January 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001277023

2001277021